Enticawer release-controllable capsules and their preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUNSHINE LAKE PHARM CO LTD
- Publication Date
- 2007-09-05
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention relates to a medicine which is convenient to take and a preparation method thereof, in particular to an entecavir controlled-release capsule for treating various hepatitis and a preparation method thereof. Background technique
[0002] Chronic hepatitis B is a serious disease caused by hepatitis B virus HBV, and it is also one of the diseases with high morbidity and mortality in the world. The virus can cause lifelong infection, liver fibrosis or cirrhosis, liver cancer, liver failure and death. Anti-HBV is the main method for the treatment of chronic hepatitis B, that is, to block or permanently inhibit the replication of hepatitis B virus HBV in the body, so as to reduce or terminate liver inflammation, necrosis and fibrosis, and prevent the disease from progressing to liver function decompensation, cirrhosis, liver disease, etc. Functional failure and liver cancer development. Commonly used effective drugs for the treatment of chroni...